Video Demo: Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension - Part 1
Christopher B. Cooper, MD, PhD
Alexander Sherman, MD
Overview of New ERS/ESC Guideline Recommendations
Richard N. Channick, MD
Case Study: CTD-PAH
Siyuan Cao, MD
Focus on CTD-PAH and Rheumatology
Suzanne Kafaja, MD
Michael Lewis, MD
Rajan Saggar, MD
Shelley Shapiro, MD, PhD
Antoine Hage, MD
Focus on Lung-Disease Associated PH
Houda Boucekkine, MD
Yuri Matusov, MD
Sivagini Ganesh, MD, MPH
Link Between Parenchymal Lung Disease and PH
Case Study: CPET
Adam J. Brownstein, MD
Pulmonary Hypertension in Rheumatic Diseases - Part 2
Focus on CTEPH/CTED
Khushboo Goel, MD
Michael Troy, MD
Sonia Jasuja, MD
Pulmonary Hypertension in Rheumatic Diseases - Part 1
West Regional Pulmonary Hypertension Summit – A Case-Based Look At Diagnosis and Treatment
Brandon Jakubowski, MD
Clinical Implications of Updated Heart Failure Nomenclature Part 1
Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA
Lysosomal Storage Disorders: Recognizing and Addressing a Group of Rare Conditions
Sarah Viall, MSN, PPCNP-BC
Neal Weinreb, MD, FACP
Combined ESC Guidelines for the Entire ACS Spectrum
Case Study: CTEPH
Diagnosis & Treatment of Chronic Thromboembolic Pulmonary Hypertension
Case Study: Group 3 PH Pulmonary Hypertension Due to Chronic Lung Disease
First ESC Guidelines on Cardiomyopathies Management
First ESC Guidelines on Cardiomyopathies - Diagnosis
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Identifying Cardiovascular Risk Factors for HIV Patients
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Steve Grinspoon, MD
Exploring Emerging Non-Statin LDL Lowering Therapies
Alan S. Brown, MD, FACC, FAHA, FNLA
Maya S. Safarova, MD, PhD, FNLA
Clinical Implications of Updated Heart Failure Nomenclature Part 2
Increasing the Uptake of Flu Vaccines Across the Age and Risk Spectrum
Mary Knudtson, DNSc, NP, FAAN
Martin C. Mahoney, MD, PhD
Transformation of Treatment Strategies for ATTR Amyloidosis
Aficamten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (REDWOOD-HCM Cohort 4)
Ahmad Masri, MD, MS
WHO? Characterizing Vericiguat Use in a Real-World HFrEF Patient Population
Marat Fudim, MD, MHS
Efficacy and Safety of Macitentan Tadalafil Fixed Dose Combination in Pulmonary Arterial Hypertension: Results From the Phase III A DUE Study
Kelly Chin, MD
Consistent Benefit of Rivaroxaban Early and Late After Lower Extremity Revascularization
Marc P. Bonaca, MD, MPH
Applicability of the GALACTIC-HF Trial and Omecamtiv Mecarbil to Patients Hospitalized for Heart Failure in the US: The GWTG-HF Registry
Stephen J. Greene, MD, FACC, FHFSA
Loading...
Stay current with the latest cardiovascular education
NEW FEATURES:
Tell us what you think by using our Feedback button
We’re glad to see you’re enjoying Global Cardiology Academy…but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.